newsfilter
← Latest News
Business Wire·

Appili Therapeutics Reports Fiscal Year 2022 Financial and Operational Results

Appili Therapeutics Inc. (TSX:APLI, OTCQX:APLIF) (the "Company" or "Appili"), a biopharmaceutical company focused on drug development for infectious diseases and biodefense, today announced its financial and operational results for the fiscal year ended